How to Use AI in Regulatory Affairs: The Practitioner's Guide

You keep hearing what AI does for other people, probably via LinkedIn posts about workflows that sound like science fiction. Meanwhile you're staring at the same submission timeline you had last year, wondering what exactly everyone else knows that you don't.

The reality is that they don't know more than you. They just started.

This guide is the starting point for regulatory professionals who want to put generative AI to work. Every workflow in it assumes you work somewhere with rules, because you do. Nothing here requires new software, a validation project, or permission from IT to experiment on public information.

I've been working with QA and regulatory affairs professionals for over 15 years and have been providing AI upskilling sessions to life science professionals since the technology emerged. I understand what a fundamental shift this is having on the industry and how we all can benefit from the speed, accuracy, and depth of analysis these remarkable tools can achieve, and I hope to share this knowledge with anyone ready to get started.

What AI can actually do for regulatory work

Artificial intelligence in regulatory affairs sounds abstract until you connect it to tasks already on your list. So before the deep dives, here's the landscape in one table. "Risk" refers to what happens if the AI gets it wrong and you don't catch it, which is the only risk framing that actually matters day to day. I like to call this "the last mile".

Regulatory task	What AI does for it	Effort to start	Risk if unchecked
Summarizing guidance, regulations, and literature	Reads 60 pages so you read 6	Minutes	Low
Drafting submission and response documents	Produces a real first draft from your outline and source material	An afternoon	Medium
Comparing health-authority feedback	Finds patterns across queries and letters you'd never line up manually	An hour	Medium
Regulatory intelligence and monitoring	Turns "keeping up" from a weekend chore into a standing workflow	An afternoon to set up	Low
Meeting, query, and inspection prep	Rehearses potential questions before the agency asks them	An hour	Low–medium
Labeling, translation, and consistency checks	Catches discrepancies across documents at a speed no human can match	An hour	High

Pick the row that matches something already on your to-do list and jump to it. If you're brand new to this, start with the first one. It's the lowest-stakes, fastest-payoff task in regulatory work, and it will teach you how these tools think.

Use case 1: Summarizing guidance, regulations, and literature

The task. A new draft guidance was released, or you've been handed a 90-page reflection paper, or you need to get current on a therapeutic area before the next meeting. Reading it all properly would take a day you don't have, so it sits in the "important, not urgent" pile until it becomes urgent.

What AI does for it. Modern AI models are excellent at reading long documents and answering questions about them. Upload the guidance (or paste the text) and ask for a structured summary, then interrogate it the way you'd interrogate a colleague who read it first. What changed from the previous version? What's the impact on combination products? Which sections mention post-market obligations?

A prompt to steal:

I'm a regulatory affairs professional in [pharma/biotech/devices]. Attached is [document name]. Summarize it in three parts: (1) what this document requires or recommends, in plain language, (2) what's new or different compared to current practice, and (3) which sections I should read in full myself, with a one-line reason for each. Quote section numbers so I can verify everything against the source.

That last sentence is very important. Asking for section numbers turns the summary from something you have to trust into something you can check in a few seconds.

The payoff. So now your reading pile stops being a pile. You walk into meetings having actually engaged with the document instead of skimming the executive summary in the elevator.

A 60-second test before you trust the summaries. Some tools read every page you give them. Others quietly retrieve the fragments that look most relevant to your question and summarize those, while sounding like they read everything. Guidance documents punish that shortcut, because the rule lives in one section and the exception lives in another, and a fragment-reader hands you the rule without the exception. So test your tool once, on a long document you already know well. Ask it what the final annex says, then ask whether anything elsewhere in the document qualifies what the summary section says. A whole-document reader answers both easily. If yours gets vague, wrong, or oddly confident, you can still use it — just work section by section instead of requesting one grand summary, and end every session with "which sections did you not cover?"

The guardrail. For published, public documents you're summarizing for your own understanding, you don't need anyone's approval. Just do it.

Use case 2: Drafting submission and response documents

The task. The blank page. A clinical overview section, a briefing document, a response to a deficiency letter. A regulatory writer roughly knows what a document needs to say and submission-quality prose, but the drafting itself takes a substantial amount of time — whether the output is an internal memo or a section bound for a regulatory submission.

What AI does for it. Treat the AI as a fast, tireless first-drafter that works from your raw material. Give it your outline or template, your source data, the specific points you need to land, and any format requirements, and it will produce a draft in minutes that would have taken you a day (sometimes longer). The draft won't be finished. That's fine, because editing a competent draft is dramatically faster than writing from nothing, and it's work you can do with your regulatory judgment fully engaged instead of your prose-generation engine.

A prompt to steal:

You're helping me draft [section/document type] for [context]. Here is my outline: [outline]. Here are the source facts you may use — do not introduce any information beyond this: [data, findings, references]. Write a first draft in [tone/format requirements]. Where my outline is thin or the source material doesn't support a claim, insert [GAP: describe what's missing] rather than filling it in yourself.

The "do not introduce information beyond this" instruction and the [GAP] convention are doing the compliance part of the work here. You're constraining the model to your sources and making its uncertainty visible instead of letting it improvise. The more capable the model, the more likely it will adhere to your instructions and constraints, so I always recommend trying it out with different models if it doesn't quite work the first time.

The payoff. First drafts in minutes instead of days, and your review time goes into substance rather than sentence construction.

The guardrail. Treat the output exactly like a draft from a bright junior colleague on their first week: useful, fast, and reviewed line by line before it goes anywhere.

Use case 3: Comparing and analyzing health-authority feedback

The task. You've received three rounds of queries across two procedures, or you're preparing a submission and want to know what the authority pushed back on last time, or your team keeps getting variations of the same question and nobody has connected the dots.

What AI does for it. Pattern-finding across documents is one of the things these models do best. Feed it a set of queries, deficiency letters, or meeting minutes and ask it to categorize the concerns, identify recurring themes, and flag which responses seemed to satisfy the reviewer versus which triggered follow-ups. You'll see your own regulatory history the way a fresh, obsessively thorough analyst would see it.

A prompt to steal:

Here are [N] health-authority queries we've received on [product/topic area] over [timeframe]. Categorize them by underlying concern (not by the section they cite). For each category, tell me: how often it appears, whether the concern escalated or resolved across rounds, and what the pattern suggests the reviewer is really worried about. Present it as a table, then give me your three most defensible observations.

The payoff. You stop answering queries one at a time and start addressing the concern underneath them, which is what actually shortens the back-and-forth.

The guardrail. Authority correspondence about your products is confidential company information, so run this on an approved enterprise AI tool rather than a public one, and confirm which tools your company has cleared before you paste anything in.

Use case 4: Regulatory intelligence and monitoring

The task. Staying current. New guidances, competitor approvals, committee outcomes, consultation deadlines. Everyone agrees it's essential and almost everyone does it badly, because it's nobody's actual job and it competes with deadlines that are.

What AI does for it. Two things. First, on-demand orientation: when something lands, you can get from "I heard about this" to "I understand what it means for us" in fifteen minutes using the summarization workflow from use case 1. Second, standing digests: AI tools with web access can check your sources on a schedule and produce a briefing in your format, so the monitoring happens whether or not you had a free morning.

A prompt to steal (for the digest version):

Check the following sources for anything published in the last two weeks relevant to [therapeutic area / product type / region]: [list of sources]. For each relevant item, give me: what it is, one paragraph on why it matters for a company like [description], any deadline or comment period, and a link. If nothing relevant appeared, say so plainly rather than stretching.

That last instruction is there because AI models hate returning empty-handed and will pad a quiet week with marginal items unless you explicitly give them permission not to.

The payoff. The hour a week you currently spend feeling guilty about not monitoring becomes twenty minutes of reading an actual briefing. Do it with a coffee in hand, and it might even be enjoyable.

The guardrail. Anything that ends up in a decision or a document gets verified at the primary source first, because a monitoring digest is a map and not the territory.

Use case 5: Preparing for meetings, queries, and inspections

The task. A scientific advice meeting, an agency teleconference, an inspection where you know which topics are sensitive. The preparation that separates a good meeting from a not so good one is anticipating the hard questions, and that anticipation usually depends on whoever has been in the RA game the longest.

What AI does for it. It plays the other side of the table. Give it your briefing package or position summary and ask it to be a skeptical reviewer. It will generate the questions, poke at the weak spots in your argument, and let you rehearse answers before the stakes are real. It's not a substitute for your team's experience, but it's a remarkably good supplement, partly because it has no incentive to be overly polite to you.

A prompt to steal:

You are a skeptical [FDA/EMA/other] reviewer assessing the attached [briefing document/position]. Generate the fifteen hardest questions you would ask, ordered from most to least likely to be raised. For the top five, describe what a weak answer would sound like and what a strong answer would need to include. Be adversarial; do not soften.

The payoff. You walk in having already survived the worst version of the meeting.

The guardrail. Same confidentiality rule as use case 3: approved tools only for anything product-specific, and the rehearsal answers you develop still get pressure-tested with your actual team.

Use case 6: Labeling, translation, and consistency checks

The task. Verifying that the SmPC, the PIL, the carton, and the promotional claims all say the same thing, or that the translated version says what the source version says, across dozens of documents and versions. It's exacting, repetitive work where a single missed discrepancy has real consequences, which is a combination humans struggle with sustaining.

What AI does for it. Cross-document comparison at machine speed. Give it two documents and ask for every substantive discrepancy: dosing statements, contraindications, storage conditions, claims present in one and absent in the other. For translations, ask it to back-translate and flag divergences in meaning rather than wording. It will catch things a tired human eye slides right past.

A prompt to steal:

Compare the attached documents: [A] and [B]. List every substantive discrepancy in a table with three columns: the text in A, the corresponding text in B, and why the difference matters (or "cosmetic" if it doesn't). Pay particular attention to numbers, units, dosing, contraindications, and safety statements. Do not summarize; be exhaustive.

The payoff. The consistency review that took two people two days takes one person one morning, with better coverage.

The guardrail. This is the high-stakes end of the spectrum, so the rule is absolute: AI output here is a screening pass that directs human review, and every flagged discrepancy plus a sample of unflagged sections gets verified by a qualified person before anything is released. The AI finds candidates; humans make findings.

How to catch AI's mistakes in 30 seconds

The skill that separates people who use AI well from people who get burned by it is quick verification.

AI models fail in predictable ways, which is what makes them checkable. The five failure modes that matter in regulatory work:

Invented citations. The model produces a plausible-looking reference to a guidance section, a regulation number, or a paper that doesn't exist or doesn't say what's claimed. The 30-second check is to open the source and look, which is why every summarization prompt in this guide demands section numbers. A citation you can't verify in under a minute should be treated as fiction until proven otherwise.

Confident interpretation beyond the text. Ask what a guidance "means for" your situation and the model will answer fluently, blending what the document says with what documents like it usually say. The check is to ask "quote the exact passage that supports that" and watch what happens. If it can't, you've found the boundary between the document and the model's improvisation.

Stale knowledge. The model's training has a cutoff date, and regulatory reality doesn't. Anything involving "current," "latest," or "in effect" gets checked against the live source. If your tool can search the web, make it do so and show you the links.

Silent gap-filling. Given incomplete source material, the model fills holes seamlessly instead of flagging them, which is precisely backwards for regulated work. The fix is structural: instruct it to mark gaps (the [GAP] convention from use case 2) so absence stays visible.

The tool that didn't read the whole document. Some document-chat setups retrieve fragments rather than reading end to end, and a summary built from fragments systematically drops the exceptions, cross-references, and annex qualifiers that change what a guidance actually permits. Worse, the error always leans the same way, toward a simpler document that allows more than the real one does. The check is the 60-second test from use case 1, plus the standing habit of asking "which sections did you not cover?" whenever a summary feels suspiciously tidy.

All of this is workable once the checks become reflexes, because at that point they cost you almost nothing. The people who skip them will be faster, but obviously that doesn't matter; they are increasing risk to an unacceptable level when doing so.

A note on compliance

Everything above is designed to be defensible in a regulated environment: public information handled freely, confidential information kept to approved tools, human review scaled to stakes, and AI uncertainty made visible instead of smoothed over. If you need the fuller picture — what's actually GxP-safe, what your QA team will ask, what to document and when — get in touch about a custom workshop for your team. This page is about what you can do; a workshop is about what your team can defend together.

Where regulators stand (the short version)

Regulators are not anti-AI, and I like to highlight this because so much internal caution assumes they are. The FDA has published draft guidance on using AI to support regulatory decision-making, built around a risk-based credibility framework: define the context of use, assess the risk, and match your evidence to it. The EMA has taken a similar direction in its reflection paper on AI across the medicinal product lifecycle, and the EU GMP framework is being extended to address AI in manufacturing contexts. The consistent theme across all of it is proportionality. Regulators want to see that you understand what the AI is doing, that a human is accountable for the output, and that your controls match the risk of the task, which is exactly the calibration this guide has been teaching.

Primary sources

• FDA — Considerations for the Use of AI to Support Regulatory Decision-Making for Drug and Biological Products
• EMA & FDA — Common principles for AI in medicine development
• EMA — Reflection paper on the use of AI in the medicinal product lifecycle (PDF)

The skills that compound

Tools will keep changing. The skills underneath them won't, so here are four of them I always recommend incorporating into your professional skillset.

Prompt literacy for regulated content. You've seen the pattern in every prompt above: state your role and context, constrain the sources, demand verifiability, make uncertainty visible. That pattern transfers to every tool and every task.

Verification as reflex. The 30-second checks from the mistakes section, run without having to remember to run them.

Knowing when not to use AI. Some tasks fail the cost-benefit test the moment you account for review burden or data sensitivity. Being able to articulate why you didn't use AI for something is as much a professional skill as using it well.

Evaluating new tools without the demo goggles. Vendors will show you the best case. The skill is designing the ten-minute test that reveals the worst case, using your own documents and your own edge cases.

These four are teachable, and they're what we build in our LabScale AI workshops, because a team that shares them moves faster than any individual enthusiast can alone.

FAQ

How do I start using AI in regulatory affairs? Start with summarization (use case 1 above): take a published guidance you need to read anyway, run the summary prompt, and verify a few section references. It's zero-risk, takes twenty minutes, and teaches you how these tools behave before you use them on anything that matters.

What can AI realistically do for regulatory professionals today? Summarize and interrogate long documents, produce first drafts from your source material, find patterns across authority feedback, run monitoring digests, rehearse hard questions, and screen documents for inconsistencies. What it can't do is be accountable, which is why every workflow keeps a human decision at the end.

Can I use ChatGPT for regulatory documents? For public information, generally yes. For confidential or product-specific content, only through an enterprise tool your company has approved, never a free public account.

Will AI replace regulatory affairs professionals? The work is changing shape rather than disappearing. Tasks like first-drafting and document comparison are being automated; judgment, strategy, and accountability aren't, and regulators are explicit that a human must own the output. The professionals at risk are the ones who don't learn the tools, not the profession itself.

What AI skills should I build first? In order: writing constrained prompts (role, sources, verifiability), fast verification of AI output, and judging when a task isn't worth AI at all. Tool-specific features come last, because tools change and those three don't.

Do I need my company's permission to start? For summarizing public documents on your own account of a general-purpose tool, no. The moment company or product information is involved, you need to know which tools are approved, and if the answer is "none yet," that's a conversation worth starting this month.